Dr Frank Giordano speaks to ecancer about the INTRAGO phase 3 study and about IORT at the University Hospital Heidelberg. Initially, he explains the background and study design of the INTRAGO phase 3 study.
This trial is actively recruiting and will report the results in the next few years.
Dr Giordano then talks about IORT at his institute. He discusses multidisciplinary collaboration, the method of IORT usage, and tumour types that are treated with it.
He concludes by giving advice on best practices with IORT.